Clinical Trial: Immunogenicity of Cholera Vaccine in Children With IBD

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT03998449) titled 'Immunogenicity of Cholera Vaccine in Children With IBD' on June 24.

Brief Summary: Assessment of the immunogenicity and safety of immunization against cholera in children with inflammatory bowel disease.

Study Type: Interventional

Condition: * Cholera

* Inflammatory Bowel Diseases

Intervention: Biological: Vaccination against cholera

Participants will receive two doses of an oral cholera vaccine with an interval of 2-4 weeks.

Recruitment Status: Recruiting

Sponsor: Medical University of Warsaw

Information provided by (Responsible Party): Lukasz Dembinski, Medical University of Warsaw

Published by HT Digital Content Services...